Circadian Health Innovations

About

Circadian Health Innovations' MiEye is a torso-mounted wearable light sensor with an app that measures exposure, computes a 'light score', and provides recommendations for sleep, shift work and jet-lag.

Mission

Circadian Health Innovations (CHI) has developed MiEye, a wearable light pin plus a linked app that continuously monitors users' light exposure and provides real-time recommendations to optimise sleep quality, mood stability, and long-term health. The device attaches to the upper torso, produces a 'light score' that evaluates the effects of different light types, and is designed to support use cases such as jet-lag adaptation, shift-work management, productivity optimisation, and workplace safety. CHI is initially targeting the research market, estimating a TAM of at least USD $70 million and a Serviceable Obtainable Market of $18 million per year, with expected annual growth of 4–8%. Product development has progressed to a mass-manufacturable design (Good Design award, 2022) and CHI retains IP over data use for customer solutions. Founders Sean Cain and Andrew Phillips are Harvard-trained, Monash-affiliated scientists with extensive publication and grant records, which CHI cites as a competitive advantage versus current competitors. Early commercial traction includes more than $1 million in presales interest from the research market.

Quick Facts